Innovative Nanomaterials in Precision Oncology: Carbon Quantum Dots Driving Cancer Immunotherapy

Area of Science:

• Nanomedicine
• Biomedical Engineering
• Materials Science

Background:

• Precision oncology seeks personalized cancer treatments, with immunotherapy emerging as a key area.
• Nanotechnology and nanomaterials offer significant potential for advancing cancer immunotherapy.
• Existing literature inadequately covers advances in nanomaterials for precision oncology.

Purpose of the Study:

• To review the recent advances in carbon quantum dots (CQDs) for precision oncology.
• To highlight the potential of CQDs in targeted drug delivery, bioimaging, and cancer immunomodulation.
• To address the gap in biomedical literature regarding nanomaterial applications in cancer treatment.

Main Methods:

• Expert review of current literature on carbon quantum dots (CQDs) in cancer research.
• Analysis of CQDs' physicochemical properties and their applications in targeted therapy.
• Evaluation of CQDs' role in bioimaging and immunomodulation for cancer treatment.

Main Results:

• Carbon quantum dots (CQDs) possess unique properties like fluorescence, conductivity, and stability, making them versatile for cancer applications.
• CQDs enable precise tumor targeting, efficient drug delivery, and real-time monitoring of treatment.
• CQDs demonstrate potential in stimulating immune responses and modulating the tumor microenvironment.

Conclusions:

• Carbon quantum dots (CQDs) are a promising next-generation nanomaterial for precision oncology and nanomedicine.
• Further research on CQD synthesis standardization and toxicological profiling is crucial for clinical translation.
• Optimizing CQD formulations can lead to safer, more effective, and personalized cancer therapies.